Morgan Stanley’s YD Bio Ltd YDES Stock Holding History

Morgan Stanley’s Portfolio YDES Stock Details YDES Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.72K	Sell	223 -76	-25%	-$734	﹤0.01%	7355
2025 Q4	$3.65K	Sell	299 -9,958	-97%	-$134K	﹤0.01%	7126
2025 Q3	$200K	Buy	+10,257	New	+$178K	﹤0.01%	5889

Other funds holding YDES

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley's YDES Position: Q1 2026 in Review

Morgan Stanley reduced its YD Bio Ltd (YDES) stake by 25% in Q1 2026, selling an estimated $734 and leaving 223 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #7355.

Morgan Stanley first reported a position in YDES in Q3 2025 and has held it in 3 quarters since. The position peaked at $200K in Q3 2025. 8 funds tracked by Wall St. Rank hold YDES as of Q1 2026.

Morgan Stanley held 223 shares of YD Bio Ltd worth $1.72K as of Q1 2026.
Morgan Stanley sold 76 YD Bio Ltd shares in Q1 2026, an estimated $734.
YD Bio Ltd made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7355 holding.
Morgan Stanley first reported a position in YD Bio Ltd in Q3 2025 and has held it in 3 quarters since.
Morgan Stanley's YD Bio Ltd position peaked at $200K in Q3 2025.
8 funds tracked by Wall St. Rank held YD Bio Ltd as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.